In absolute terms, participants receiving semaglutide lost 15.3 kg compared with 2.6 kg in the placebo group
This gradual escalation improves tolerability and long-term adherence compared to faster dose progression
Vijiaratnam N, Girges C, Auld G, McComish R, King A, Skene SS, Hibbert S, Wong A, Melander S, Gibson R, Matthews H, Dickson J, Carroll C, Patrick A, Inches J, Silverdale M, Blackledge B, Whiston J, Hu M, Welch J et al (2025) Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
During the holidays, BMI is helpful for one reason: it reminds you that this journey is about health trends over timenot what the scale does between December 20 and January 2